This important collaboration between Eccogene and AstraZeneca will accelerate the development of ECC5004, a once daily, low dose, orally available small molecule GLP-1RA to benefit the millions of patients worldwide living with these diseases." Sharon Barr, Executive Vice President, BioPharmaceuticals R&D at AstraZeneca, said: "With the number of people living with cardiometabolic conditions and obesity today already over one billion, there is a need for continued innovation and next generation therapeutic options
Ipamorelin boosts energy levels
High-altitude erythrocytosis: mechanisms of adaptive and maladaptive responses
, GLP-1
One flat monthly price: $129/mo covers everything
Business Type Exporter, Supplier, Trading Company Employee Count 10 Establishment 2025 Working Days To GST NO 27AAPCP2975H1ZU Payment Mode Online Payments (NEFT/RTGS/IMPS), Cheque/DD, Wallet & UPI Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27AAPCP2975H1ZU Trusted Seller Navi Mumbai, Maharashtra CEO Mr